StockData
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.84+0.11 (+6.36%)

Close on Oct 19, 2026

Market cap
$571.61M
P/E (TTM)
–
Dividend yield
0.00%

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product revenue$32.95M$31.53M$38.97M$32.60M$33.08M$31.11M$34.10M$35.30M$31.75M$35.01M$54.00M$51.56M84.5%-0.4%
Consumable revenue$20.11M$21.81M$21.63M$21.28M$18.93M$20.10M$18.81M$18.51M$17.07M$15.98M$18.87M$16.87M51.6%+6.2%
Instrument revenue$12.84M$9.72M$17.34M$11.32M$14.15M$11.02M$15.29M$16.79M$14.68M$19.03M$35.13M$34.69M32.9%-9.3%
Service and other revenue$6.06M$5.64M$5.68M$5.84M$6.68M$6.04M$5.13M$4.67M$4.27M$3.80M$4.36M$4.13M15.5%-9.4%

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Americas$17.62M$16.69M$20.71M$18.10M$17.69M$16.30M$20.17M$20.11M$20.76M$17.68M$33.93M$28.98M45.2%-0.4%
Europe, Middle East and Africa$14.43M$10.77M$14.59M$10.75M$9.47M$9.24M$10.10M$9.12M$7.02M$8.36M$11.06M$10.99M37.0%+52.4%
Asia-Pacific$6.96M$9.72M$9.34M$9.59M$12.61M$11.61M$8.96M$10.74M$8.23M$12.78M$13.36M$15.72M17.8%-44.8%

From the segment and revenue-disaggregation notes of Pacific Biosciences Of California's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.